Selected research
Industry Research
Drug Allergy Treatments and Drugs Industry Research Report 2026
Market perspective
The global Drug Allergy Treatments and Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Drug Allergy Treatments and Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Drug Allergy Treatments and Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Drug Allergy Treatments and Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Drug Allergy Treatments and Drugs include AAFA, Allergan plc, Allergy Therapeutics, Circassia, HAL Allergy Group, Mayo Clinic, Stallergenes Greer, Sunovion Pharmaceuticals and GlaxoSmithKline plc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Drug Allergy Treatments and Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Drug Allergy Treatments and Drugs Market by Company
AAFA
Allergan plc
Allergy Therapeutics
Circassia
HAL Allergy Group
Mayo Clinic
Stallergenes Greer
Sunovion Pharmaceuticals
GlaxoSmithKline plc
Teva Pharmaceutical Industries
Drug Allergy Treatments and Drugs Segment by Type
Insulin
Penicillin and Related Drugs
Sulfa Drugs
Chemotherapy Drugs
Iodine
Other
Drug Allergy Treatments and Drugs Segment by Application
Pharmaceutical & Biotechnology Companies
Diagnostic Laboratories
Hospitals
Research & Academic Laboratories
Drug Allergy Treatments and Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Allergy Treatments and Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drug Allergy Treatments and Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Allergy Treatments and Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Drug Allergy Treatments and Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Drug Allergy Treatments and Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Drug Allergy Treatments and Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Insulin
- Penicillin and Related Drugs
- Sulfa Drugs
- Chemotherapy Drugs
- Iodine
- Other
Applications
- Pharmaceutical & Biotechnology Companies
- Diagnostic Laboratories
- Hospitals
- Research & Academic Laboratories
Companies covered
- AAFA
- Allergan plc
- Allergy Therapeutics
- Circassia
- HAL Allergy Group
- Mayo Clinic
- Stallergenes Greer
- Sunovion Pharmaceuticals
- GlaxoSmithKline plc
- Teva Pharmaceutical Industries
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Drug Allergy Treatments and Drugs Market Size (2021-2032)
- 2.2.2 Global Drug Allergy Treatments and Drugs Sales (2021-2032)
- 2.2.3 Global Drug Allergy Treatments and Drugs Market Average Price (2021-2032)
- 2.3 Drug Allergy Treatments and Drugs by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Insulin
- 2.3.3 Penicillin and Related Drugs
- 2.3.4 Sulfa Drugs
- 2.3.5 Chemotherapy Drugs
- 2.3.6 Iodine
- 2.3.7 Other
- 2.4 Drug Allergy Treatments and Drugs by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Pharmaceutical & Biotechnology Companies
- 2.4.3 Diagnostic Laboratories
- 2.4.4 Hospitals
- 2.4.5 Research & Academic Laboratories
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Drug Allergy Treatments and Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Drug Allergy Treatments and Drugs Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Drug Allergy Treatments and Drugs Revenue of Manufacturers (2021-2026)
- 3.4 Global Drug Allergy Treatments and Drugs Average Price by Manufacturers (2021-2026)
- 3.5 Global Drug Allergy Treatments and Drugs Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Drug Allergy Treatments and Drugs, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Drug Allergy Treatments and Drugs, Product Type & Application
- 3.8 Global Manufacturers of Drug Allergy Treatments and Drugs, Established Date
- 3.9 Global Drug Allergy Treatments and Drugs Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 AAFA
- 4.1.1 AAFA Company Information
- 4.1.2 AAFA Business Overview
- 4.1.3 AAFA Drug Allergy Treatments and Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 AAFA Drug Allergy Treatments and Drugs Product Portfolio
- 4.1.5 AAFA Recent Developments
- 4.2 Allergan plc
- 4.2.1 Allergan plc Company Information
- 4.2.2 Allergan plc Business Overview
- 4.2.3 Allergan plc Drug Allergy Treatments and Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Allergan plc Drug Allergy Treatments and Drugs Product Portfolio
- 4.2.5 Allergan plc Recent Developments
- 4.3 Allergy Therapeutics
- 4.3.1 Allergy Therapeutics Company Information
- 4.3.2 Allergy Therapeutics Business Overview
- 4.3.3 Allergy Therapeutics Drug Allergy Treatments and Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Allergy Therapeutics Drug Allergy Treatments and Drugs Product Portfolio
- 4.3.5 Allergy Therapeutics Recent Developments
- 4.4 Circassia
- 4.4.1 Circassia Company Information
- 4.4.2 Circassia Business Overview
- 4.4.3 Circassia Drug Allergy Treatments and Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Circassia Drug Allergy Treatments and Drugs Product Portfolio
- 4.4.5 Circassia Recent Developments
- 4.5 HAL Allergy Group
- 4.5.1 HAL Allergy Group Company Information
- 4.5.2 HAL Allergy Group Business Overview
- 4.5.3 HAL Allergy Group Drug Allergy Treatments and Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 HAL Allergy Group Drug Allergy Treatments and Drugs Product Portfolio
- 4.5.5 HAL Allergy Group Recent Developments
- 4.6 Mayo Clinic
- 4.6.1 Mayo Clinic Company Information
- 4.6.2 Mayo Clinic Business Overview
- 4.6.3 Mayo Clinic Drug Allergy Treatments and Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Mayo Clinic Drug Allergy Treatments and Drugs Product Portfolio
- 4.6.5 Mayo Clinic Recent Developments
- 4.7 Stallergenes Greer
- 4.7.1 Stallergenes Greer Company Information
- 4.7.2 Stallergenes Greer Business Overview
- 4.7.3 Stallergenes Greer Drug Allergy Treatments and Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Stallergenes Greer Drug Allergy Treatments and Drugs Product Portfolio
- 4.7.5 Stallergenes Greer Recent Developments
- 4.8 Sunovion Pharmaceuticals
- 4.8.1 Sunovion Pharmaceuticals Company Information
- 4.8.2 Sunovion Pharmaceuticals Business Overview
- 4.8.3 Sunovion Pharmaceuticals Drug Allergy Treatments and Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Sunovion Pharmaceuticals Drug Allergy Treatments and Drugs Product Portfolio
- 4.8.5 Sunovion Pharmaceuticals Recent Developments
- 4.9 GlaxoSmithKline plc
- 4.9.1 GlaxoSmithKline plc Company Information
- 4.9.2 GlaxoSmithKline plc Business Overview
- 4.9.3 GlaxoSmithKline plc Drug Allergy Treatments and Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 GlaxoSmithKline plc Drug Allergy Treatments and Drugs Product Portfolio
- 4.9.5 GlaxoSmithKline plc Recent Developments
- 4.10 Teva Pharmaceutical Industries
- 4.10.1 Teva Pharmaceutical Industries Company Information
- 4.10.2 Teva Pharmaceutical Industries Business Overview
- 4.10.3 Teva Pharmaceutical Industries Drug Allergy Treatments and Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Teva Pharmaceutical Industries Drug Allergy Treatments and Drugs Product Portfolio
- 4.10.5 Teva Pharmaceutical Industries Recent Developments
5 Global Drug Allergy Treatments and Drugs Market Scenario by Region
- 5.1 Global Drug Allergy Treatments and Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Drug Allergy Treatments and Drugs Sales by Region: 2021-2032
- 5.2.1 Global Drug Allergy Treatments and Drugs Sales by Region: 2021-2026
- 5.2.2 Global Drug Allergy Treatments and Drugs Sales by Region: 2027-2032
- 5.3 Global Drug Allergy Treatments and Drugs Revenue by Region: 2021-2032
- 5.3.1 Global Drug Allergy Treatments and Drugs Revenue by Region: 2021-2026
- 5.3.2 Global Drug Allergy Treatments and Drugs Revenue by Region: 2027-2032
- 5.4 North America Drug Allergy Treatments and Drugs Market Facts & Figures by Country
- 5.4.1 North America Drug Allergy Treatments and Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Drug Allergy Treatments and Drugs Sales by Country (2021-2032)
- 5.4.3 North America Drug Allergy Treatments and Drugs Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Drug Allergy Treatments and Drugs Market Facts & Figures by Country
- 5.5.1 Europe Drug Allergy Treatments and Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Drug Allergy Treatments and Drugs Sales by Country (2021-2032)
- 5.5.3 Europe Drug Allergy Treatments and Drugs Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Drug Allergy Treatments and Drugs Market Facts & Figures by Country
- 5.6.1 Asia Pacific Drug Allergy Treatments and Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Drug Allergy Treatments and Drugs Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Drug Allergy Treatments and Drugs Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Drug Allergy Treatments and Drugs Market Facts & Figures by Country
- 5.7.1 South America Drug Allergy Treatments and Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Drug Allergy Treatments and Drugs Sales by Country (2021-2032)
- 5.7.3 South America Drug Allergy Treatments and Drugs Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Drug Allergy Treatments and Drugs Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Drug Allergy Treatments and Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Drug Allergy Treatments and Drugs Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Drug Allergy Treatments and Drugs Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Drug Allergy Treatments and Drugs Sales by Type (2021-2032)
- 6.1.1 Global Drug Allergy Treatments and Drugs Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Drug Allergy Treatments and Drugs Sales Market Share by Type (2021-2032)
- 6.2 Global Drug Allergy Treatments and Drugs Revenue by Type (2021-2032)
- 6.2.1 Global Drug Allergy Treatments and Drugs Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Drug Allergy Treatments and Drugs Revenue Market Share by Type (2021-2032)
- 6.3 Global Drug Allergy Treatments and Drugs Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Drug Allergy Treatments and Drugs Sales by Application (2021-2032)
- 7.1.1 Global Drug Allergy Treatments and Drugs Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Drug Allergy Treatments and Drugs Sales Market Share by Application (2021-2032)
- 7.2 Global Drug Allergy Treatments and Drugs Revenue by Application (2021-2032)
- 7.2.1 Global Drug Allergy Treatments and Drugs Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Drug Allergy Treatments and Drugs Revenue Market Share by Application (2021-2032)
- 7.3 Global Drug Allergy Treatments and Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Drug Allergy Treatments and Drugs Value Chain Analysis
- 8.1.1 Drug Allergy Treatments and Drugs Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Drug Allergy Treatments and Drugs Production Mode & Process
- 8.2 Drug Allergy Treatments and Drugs Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Drug Allergy Treatments and Drugs Distributors
- 8.2.3 Drug Allergy Treatments and Drugs Customers
9 Global Drug Allergy Treatments and Drugs Analyzing Market Dynamics
- 9.1 Drug Allergy Treatments and Drugs Industry Trends
- 9.2 Drug Allergy Treatments and Drugs Industry Drivers
- 9.3 Drug Allergy Treatments and Drugs Industry Opportunities and Challenges
- 9.4 Drug Allergy Treatments and Drugs Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst